Ambev Competitors

Philip Morris International (NYSE:PM) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Dividends

Philip Morris International pays an annual dividend of $4.80 per share and has a dividend yield of 5.5%. Ambev pays an annual dividend of $0.01 per share and has a dividend yield of 0.4%. Philip Morris International pays out 92.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ambev pays out 5.3% of its earnings in the form of a dividend. Philip Morris International has increased its dividend for 12 consecutive years. Philip Morris International is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Philip Morris International and Ambev, as reported by MarketBeat.

Philip Morris International currently has a consensus target price of $96.8182, suggesting a potential upside of 10.57%. Given Philip Morris International's stronger consensus rating and higher possible upside, equities research analysts plainly believe Philip Morris International is more favorable than Ambev.

Valuation and Earnings

This table compares Philip Morris International and Ambev's top-line revenue, earnings per share (EPS) and valuation.

Philip Morris International has higher revenue and earnings than Ambev. Ambev is trading at a lower price-to-earnings ratio than Philip Morris International, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

74.2% of Philip Morris International shares are owned by institutional investors. Comparatively, 8.3% of Ambev shares are owned by institutional investors. 0.2% of Philip Morris International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Philip Morris International and Ambev's net margins, return on equity and return on assets.

Volatility & Risk

Philip Morris International has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Ambev has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

Summary

Philip Morris International beats Ambev on 11 of the 17 factors compared between the two stocks.

Anheuser-Busch InBev SA/NV (NYSE:BUD) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings.

Earnings & Valuation

This table compares Anheuser-Busch InBev SA/NV and Ambev's top-line revenue, earnings per share (EPS) and valuation.

Anheuser-Busch InBev SA/NV has higher revenue and earnings than Ambev. Ambev is trading at a lower price-to-earnings ratio than Anheuser-Busch InBev SA/NV, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and target prices for Anheuser-Busch InBev SA/NV and Ambev, as provided by MarketBeat.com.

Anheuser-Busch InBev SA/NV presently has a consensus price target of $60.25, suggesting a potential downside of 7.66%. Given Anheuser-Busch InBev SA/NV's stronger consensus rating and higher possible upside, research analysts plainly believe Anheuser-Busch InBev SA/NV is more favorable than Ambev.

Volatility and Risk

Anheuser-Busch InBev SA/NV has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Comparatively, Ambev has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Dividends

Anheuser-Busch InBev SA/NV pays an annual dividend of $0.42 per share and has a dividend yield of 0.6%. Ambev pays an annual dividend of $0.01 per share and has a dividend yield of 0.4%. Anheuser-Busch InBev SA/NV pays out 10.3% of its earnings in the form of a dividend. Ambev pays out 5.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Anheuser-Busch InBev SA/NV and Ambev's net margins, return on equity and return on assets.

Institutional and Insider Ownership

3.8% of Anheuser-Busch InBev SA/NV shares are held by institutional investors. Comparatively, 8.3% of Ambev shares are held by institutional investors. 4.5% of Anheuser-Busch InBev SA/NV shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Anheuser-Busch InBev SA/NV beats Ambev on 9 of the 16 factors compared between the two stocks.

The Estée Lauder Companies (NYSE:EL) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

Valuation and Earnings

This table compares The Estée Lauder Companies and Ambev's top-line revenue, earnings per share (EPS) and valuation.

Ambev has lower revenue, but higher earnings than The Estée Lauder Companies. Ambev is trading at a lower price-to-earnings ratio than The Estée Lauder Companies, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

55.0% of The Estée Lauder Companies shares are owned by institutional investors. Comparatively, 8.3% of Ambev shares are owned by institutional investors. 14.0% of The Estée Lauder Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for The Estée Lauder Companies and Ambev, as provided by MarketBeat.

The Estée Lauder Companies presently has a consensus price target of $273.9524, suggesting a potential downside of 6.93%. Given The Estée Lauder Companies' stronger consensus rating and higher probable upside, equities analysts plainly believe The Estée Lauder Companies is more favorable than Ambev.

Risk & Volatility

The Estée Lauder Companies has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Ambev has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500.

Profitability

This table compares The Estée Lauder Companies and Ambev's net margins, return on equity and return on assets.

Dividends

The Estée Lauder Companies pays an annual dividend of $2.12 per share and has a dividend yield of 0.7%. Ambev pays an annual dividend of $0.01 per share and has a dividend yield of 0.4%. The Estée Lauder Companies pays out 51.5% of its earnings in the form of a dividend. Ambev pays out 5.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Estée Lauder Companies has raised its dividend for 8 consecutive years. The Estée Lauder Companies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

The Estée Lauder Companies beats Ambev on 12 of the 17 factors compared between the two stocks.

Ambev (NYSE:ABEV) and Diageo (NYSE:DEO) are both large-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for Ambev and Diageo, as reported by MarketBeat.

Diageo has a consensus target price of $143.50, indicating a potential downside of 14.20%. Given Diageo's stronger consensus rating and higher probable upside, analysts plainly believe Diageo is more favorable than Ambev.

Dividends

Ambev pays an annual dividend of $0.01 per share and has a dividend yield of 0.4%. Diageo pays an annual dividend of $4.37 per share and has a dividend yield of 2.6%. Ambev pays out 5.3% of its earnings in the form of a dividend. Diageo pays out 79.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Insider & Institutional Ownership

8.3% of Ambev shares are owned by institutional investors. Comparatively, 10.1% of Diageo shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Ambev and Diageo's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Ambev and Diageo's revenue, earnings per share (EPS) and valuation.

Ambev has higher earnings, but lower revenue than Diageo. Ambev is trading at a lower price-to-earnings ratio than Diageo, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Ambev has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, Diageo has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500.

Summary

Diageo beats Ambev on 9 of the 15 factors compared between the two stocks.

Ambev (NYSE:ABEV) and British American Tobacco (NYSE:BTI) are both large-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Risk and Volatility

Ambev has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, British American Tobacco has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Insider & Institutional Ownership

8.3% of Ambev shares are owned by institutional investors. Comparatively, 5.3% of British American Tobacco shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Ambev and British American Tobacco's gross revenue, earnings per share (EPS) and valuation.

British American Tobacco has higher revenue and earnings than Ambev. British American Tobacco is trading at a lower price-to-earnings ratio than Ambev, indicating that it is currently the more affordable of the two stocks.

Dividends

Ambev pays an annual dividend of $0.01 per share and has a dividend yield of 0.4%. British American Tobacco pays an annual dividend of $2.85 per share and has a dividend yield of 7.7%. Ambev pays out 5.3% of its earnings in the form of a dividend. British American Tobacco pays out 69.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. British American Tobacco has raised its dividend for 1 consecutive years. British American Tobacco is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Profitability

This table compares Ambev and British American Tobacco's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and price targets for Ambev and British American Tobacco, as provided by MarketBeat.

Summary

Ambev beats British American Tobacco on 8 of the 15 factors compared between the two stocks.

Altria Group (NYSE:MO) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation.

Risk and Volatility

Altria Group has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, Ambev has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Insider & Institutional Ownership

62.2% of Altria Group shares are held by institutional investors. Comparatively, 8.3% of Ambev shares are held by institutional investors. 0.1% of Altria Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Altria Group and Ambev's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Altria Group and Ambev's gross revenue, earnings per share and valuation.

Ambev has lower revenue, but higher earnings than Altria Group. Altria Group is trading at a lower price-to-earnings ratio than Ambev, indicating that it is currently the more affordable of the two stocks.

Dividends

Altria Group pays an annual dividend of $3.44 per share and has a dividend yield of 7.6%. Ambev pays an annual dividend of $0.01 per share and has a dividend yield of 0.4%. Altria Group pays out 81.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ambev pays out 5.3% of its earnings in the form of a dividend. Altria Group has increased its dividend for 12 consecutive years. Altria Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Altria Group and Ambev, as provided by MarketBeat.

Altria Group presently has a consensus target price of $50.00, suggesting a potential upside of 11.11%. Given Altria Group's stronger consensus rating and higher probable upside, equities analysts clearly believe Altria Group is more favorable than Ambev.

Summary

Altria Group beats Ambev on 12 of the 17 factors compared between the two stocks.